Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY
Pharmaceutics · 30.08.2024 · 16 (9) · 1149
DOI: 10.3390/pharmaceutics16091149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 30.08.2024. Verfasst von Gentil Arthur Bentes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Instituto Oswaldo Cruz/Fiocruz.
Abstract (Originalsprache)
Immunoglobulins Y (IgY) purified from egg yolks of hens represents an attractive, cost-effective alternative for the development of new diagnostic and therapeutic platforms. In this study, we evaluated the therapeutic efficacy of rotavirus-specific IgY in a cynomolgus monkey (Macaca fascicularis) model. Animals were experimentally infected with human rotavirus Group A (RVA), the most common cause of severe acute diarrhoea among young children worldwide. Animals were administered human RVA (3.1 × 107 FFU/mL) by oral gavage, challenged with 2.5 mg of anti-RVA IgY orally, and monitored for five days according to clinical, haematological and biochemical parameters; serum electrolyte levels; viral shedding; and histopathological changes. Immunotherapy with anti-RVA IgY had a protective effect against severe rotavirus-induced enteritis in four of the ten treated monkeys, as evidenced by histopathological findings. Although only one animal had diarrhoea, all but one exhibited virus shedding regardless of the treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
- Laboratório de Virologia Comparada e Ambiental, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
- Laboratório de Ensaios Pré-Clínicos, Instituto de Tecnologia em Imunobiológicos, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
ORCID-Profile: Gentil Arthur Bentes, Natália Maria Lanzarini, Jaqueline Mendes de Oliveira, Marcelo Alves Pinto
Förderung
- National Council for Scientific and Technological Development
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Instituto Oswaldo Cruz/Fiocruz
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
- Oswaldo Cruz Institute
Zitieren
APA
Bentes, G. A., Guimarães, J. R., Volotão, E. M., Lanzarini, N. M., da Silva, A. D. S., Gardinali, N. R., Marchevsky, R. S., Leite, J. P. G., de Oliveira, J. M., & Pinto, M. A. (2024). Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY. Pharmaceutics, 16(9), 1149. https://doi.org/10.3390/pharmaceutics16091149
Vancouver
Bentes GA, Guimarães JR, Volotão EM, Lanzarini NM, da Silva ADS, Gardinali NR, et al. Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY. Pharmaceutics. 2024;16(9):1149. doi:10.3390/pharmaceutics16091149
BibTeX
@article{Bentes2024,
author = {Bentes, Gentil Arthur and Guimarães, Juliana Rodrigues and Volotão, Eduardo de Mello and Lanzarini, Natália Maria and da Silva, Alexandre Dos Santos and Gardinali, Noemi Rovaris and Marchevsky, Renato Sergio and Leite, José Paulo Gagliardi and de Oliveira, Jaqueline Mendes and Pinto, Marcelo Alves},
title = {Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {9},
pages = {1149},
doi = {10.3390/pharmaceutics16091149}
}
EUVIMED